BetterLife Pharma (BETRF) Net Cash Flow (QoQ) (2011 - 2025)
BetterLife Pharma (BETRF) Net Cash Flow (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -74.11% |
| Apr 30, 2025 | 202.29% |
| Jan 31, 2025 | 90.63% |
| Oct 31, 2024 | 63.61% |
| Jul 31, 2024 | -176.18% |
| Apr 30, 2024 | 797.10% |
| Jan 31, 2024 | -275.39% |
| Oct 31, 2023 | 116.64% |
| Jul 31, 2023 | -179.02% |
| Apr 30, 2023 | 750.50% |
| Jan 31, 2023 | -250.44% |
| Oct 31, 2022 | 1,025.25% |
| Jul 31, 2022 | 98.38% |
| Apr 30, 2022 | 92.18% |
| Jan 31, 2022 | 9.19% |
| Oct 31, 2021 | -152.47% |
| Jul 31, 2021 | 2,781.39% |
| Apr 30, 2021 | 139.80% |
| Jan 31, 2021 | 51.31% |
| Oct 31, 2020 | -67.34% |